Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan-Reference-Cited by-同舟云学术

Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan

Published:2020-10 Issue:10 Volume:119 Page:1476-1482
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Su Hau-Jyun,Kao Jia-Horng,Tseng Tai-Chung,Yang Hung-Chih,Su Tung-Hung,Chen Pei-Jer,Liu Chun-Jen

Funder

Ministry of Science and Technology and Ministry of Health and Welfare, Executive Yuan, Taiwan

National Taiwan University Hospital

Hepatitis Research Center, National Taiwan University Hospital

Publisher

Elsevier BV

Subject

General Medicine

Reference35 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nature Reviews Gastroenterology & Amp; Hepatology,2017

2. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults;Chen;J Clin Gastroenterol,2006

3. Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan;Shen;Clin Interv Aging,2014

4. Nonalcoholic fatty liver disease severity is associated with the ratios of total cholesterol and triglycerides to high-density lipoprotein cholesterol;Wu;J Clin Lipidol,2016

5. Prevalence and related factors of non-alcoholic fatty liver disease among the elderly in Taiwan;Hung;European Geriatric Medicine,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Citrus depressa Hayata juice on high-fat diet-induced obesity in HBV transgenic mice;Heliyon;2024-01

2. Metabolic Dysfunction-Associated Steatotic Liver Disease Facilitates Hepatitis B Surface Antigen Seroclearance and Seroconversion;Clinical Gastroenterology and Hepatology;2023-10

3. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B;Hepatology International;2023-05-29

4. Liver fibrosis is closely related to metabolic factors in metabolic associated fatty liver disease with hepatitis B virus infection;Scientific Reports;2023-01-25

5. Hepatitis B virus infection combined with nonalcoholic fatty liver disease: Interaction and prognosis;Heliyon;2023-01